Across TCGA pan-cancer cohorts, GRM7-AS3 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated GRM7-AS3 data layer.
The strongest signal is observed in thyroid carcinoma (THCA), where higher GRM7-AS3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GRM7-AS3 expression acts as an unfavorable survival marker, although some lineages such as COAD and KIRC show a favorable association.
THCA, KIRP, and ACC are the cancer types where GRM7-AS3 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.